Susquehanna International Group, LLP I Bio, Inc. Transaction History

Susquehanna International Group, LLP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.23 - $160.0 $4,537 - $3.16 Million	19,729 Added 3.6%	568,135 $97,000
Q2 2022 Aug 15, 2022	BUY	$0.23 - $0.46 $68,609 - $137,218	298,301 Added 119.27%	548,406 $145,000
Q1 2022 May 16, 2022	SELL	$0.3 - $0.61 $279,791 - $568,909	-932,639 Reduced 78.85%	250,105 $107,000
Q4 2021 Feb 14, 2022	BUY	$0.55 - $1.04 $36,804 - $69,594	66,918 Added 6.0%	1,182,744 $649,000
Q3 2021 Nov 15, 2021	SELL	$1.06 - $1.52 $277,303 - $397,642	-261,607 Reduced 18.99%	1,115,826 $1.18 Million
Q2 2021 Aug 11, 2021	SELL	$1.22 - $1.65 $143,784 - $194,462	-117,856 Reduced 7.88%	1,377,433 $2.08 Million
Q1 2021 May 17, 2021	BUY	$1.18 - $2.62 $502,796 - $1.12 Million	426,099 Added 39.85%	1,495,289 $2.3 Million
Q4 2020 Feb 16, 2021	BUY	$1.05 - $2.24 $451,242 - $962,651	429,755 Added 67.21%	1,069,190 $1.12 Million
Q3 2020 Nov 16, 2020	BUY	$1.7 - $6.41 $1.09 Million - $4.1 Million	639,435 New	639,435 $1.3 Million
Q2 2020 Aug 14, 2020	SELL	$0.87 - $2.46 $75,451 - $213,345	-86,726 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$0.22 - $2.45 $19,079 - $212,478	86,726 New	86,726 $92,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.